title: Long-term complete remissions in patients with disseminated melanoma treated by fotemustine and dacarbazine.
authors.forename: V
authors.initials: V
authors.lastname: Oliver
authors.forename: A
authors.initials: A
authors.lastname: Aliaga
authors.forename: J J
authors.initials: JJ
authors.lastname: Lopez Lopez
authors.forename: E
authors.initials: E
authors.lastname: Perez
authors.forename: A
authors.initials: A
authors.lastname: Ponchon
authors.forename: J P
authors.initials: JP
authors.lastname: Bizzari
authors.forename: V
authors.initials: V
authors.lastname: Cour
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003606:Dacarbazine / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008297:Male; D008545:Melanoma / Q000188:drug therapy*; D008875:Middle Aged; D009607:Nitrosourea Compounds / Q000008:administration & dosage; D009943:Organophosphorus Compounds / Q000008:administration & dosage; D012074:Remission Induction
chemical_list: D009607:Nitrosourea Compounds; D009943:Organophosphorus Compounds; D003606:Dacarbazine; C054368:fotemustine